DELCATH SYSTEMS, INC.

Analyst Reco. Delcath Systems, Inc.

Equities

DCTH

US24661P8077

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
5.71 ^USD	+2.70%		+2.70%	+37.26%

May. 06	Delcath Systems Says Phase 3 Data on Hepzato Kit Published in Oncology Journal	MT
May. 06	Delcath Systems, Inc Announces Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride	Apr. 26	MT
HC Wainwright Adjusts Delcath Systems' Price Target to $20 From $18, Maintains Buy Rating	Mar. 27	MT
Canaccord Genuity Adjusts Delcath Systems Price Target to $21 From $18, Maintains Buy Rating	23-09-07	MT
Roth MKM Adjusts Price Target on Delcath Systems to $13 From $10, Maintains Buy Rating	23-08-16	MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $19, Keeps Buy Rating	23-08-16	MT
HC Wainwright Adjusts Price Target on Delcath Systems to $18 From $17, Maintains Buy Rating	23-08-15	MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $18 From $14, Keeps Buy Rating	23-08-15	MT
HC Wainwright Cuts Price Target on Delcath Systems to $17 From $19, Maintains Buy Rating	23-03-28	MT
HC Wainwright Adjusts Delcath Systems' Price Target to $19 from $25, Keeps Buy Rating	22-08-10	MT
BTIG Adjusts Delcath Systems' Price Target to $20 From $23, Reiterates Buy Rating	22-06-24	MT
Canaccord Genuity Adjusts Delcath Systems' Price Target to $20 From $24, Reiterates Buy Rating	22-04-11	MT
HC Wainwright Initiates Delcath Systems at Buy Rating With $25 Price Target	21-12-10	MT
Delcath Says Hepzato Induces Statistically Significant Response Rates in Phase 3 Trial for Ocular Melanoma	21-12-02	MT
DELCATH : Roth Capital Adjusts Delcath Systems' Price Target to $25 From $20, Maintains Buy Rating	21-04-06	MT
DELCATH : Canaccord Genuity Initiates Coverage on Delcath Systems With Buy Rating, $24 Price Target	21-03-09	MT
DELCATH : BTIG Starts Delcath Systems at Buy With $23 Price Target	21-01-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW